Electroconvulsive Therapy: Your Guide to ECT

Electroconvulsive Therapy (ECT), often shrouded in misunderstanding and historical stigma, stands today as a highly effective and safe treatment for severe mental health conditions, particularly when other therapies have proven ineffective. Far from the sensationalised portrayals, modern ECT is a carefully controlled medical procedure, delivered under general anaesthesia, offering life-changing relief for patients battling debilitating conditions.

What is Electroconvulsive Therapy (ECT)?

At its core, ECT involves inducing a brief, controlled seizure in the brain by passing a small, regulated electrical current through the scalp. This procedure is always performed under general anaesthesia and with muscle relaxants to ensure patient comfort and safety. The technique was first introduced in 1938 by Italian psychiatrists Ugo Cerletti and Lucio Bini, and while the foundational concept remains, the methodology has evolved significantly, prioritising patient well-being and minimising side effects.

Initially, ECT was performed without anaesthesia, leading to severe physical convulsions and contributing to its negative public perception. However, advancements in medical practice mean that contemporary ECT is a vastly different experience. Patients are asleep during the entire procedure, and muscle relaxants prevent any violent physical movements, making it a far safer and more humane treatment.

How Does ECT Work? Unravelling the Mechanism

While the precise mechanism by which ECT alleviates symptoms is not fully understood, current research offers compelling insights. It's believed that ECT influences the brain's neurochemistry, affecting various neurotransmitters – the chemical messengers that transfer impulses between nerve cells. By correcting certain biochemical imbalances thought to contribute to mental disorders, ECT can profoundly impact mood and thought processes.

Recent studies suggest that ECT may promote neurogenesis, the birth of new neurons, particularly in the hippocampus – a brain structure crucial for memory, emotions, and behavioural control, which often shows reduced volume in depression. Furthermore, ECT appears to enhance the survival and integration of these new neurons into existing neural networks, a process that can take several weeks. It also boosts the synthesis of crucial growth factors, such as Brain-Derived Neurotrophic Factor (BDNF) and Vascular Endothelial Growth Factor (VEGF), which are vital for neuronal health and plasticity.

A key difference between ECT and traditional antidepressants lies in their speed of action. ECT is remarkably fast-acting, often providing rapid relief in urgent situations. This swift response is potentially due to its direct influence on the integration of new neurons, whereas antidepressants may primarily affect proliferation, with the full benefits taking longer to manifest as neurons mature and integrate.

Who Can Benefit from ECT? Indications for Treatment

ECT is typically considered when other conventional treatments, such as medication and psychotherapy, have not yielded sufficient improvement. It is a highly effective option for a range of severe and treatment-resistant mental health conditions, with research indicating remission rates of 60% to 80% for individuals with depression.

Key indications for ECT include:

• Severe, Treatment-Resistant Depression: This is the most common indication, especially when symptoms haven't responded to multiple antidepressant medications or psychosocial interventions. This includes unipolar depression and severe depressive episodes within bipolar disorder.
• Delusional or Psychotic Depression: When depression presents with psychotic features, ECT can be particularly effective.
• Bipolar Disorder: Used for severe manic episodes or rapid-cycling bipolar disorder where mood stabilisers are ineffective. It can also be a prophylactic measure to prevent relapses.
• Catatonia: A severe neuropsychiatric syndrome characterised by abnormal movements, behaviours, and lack of responsiveness.
• Schizophrenia: When antipsychotic medications are ineffective, and there's a significant risk, such as suicidal ideation or severe disorganisation.

ECT is also a valuable treatment in gerontopsychiatry. Elderly patients often show greater resistance to antidepressant medications, and the side effects of these drugs can be more pronounced with age. ECT offers high remission rates (60-90%) for major depression in older adults, providing a safe and effective alternative.

Contraindications and Pre-Treatment Assessment

Before undergoing ECT, a thorough medical evaluation is crucial to ensure patient safety. This assessment determines the risk-benefit ratio and identifies any potential contraindications.

The only absolute contraindication is increased intracranial pressure (e.g., due to a brain tumour or recent stroke). All other contraindications are considered relative, meaning ECT may still be performed if the anticipated benefits outweigh the risks, under close medical supervision. These relative contraindications include:

• Recent cerebral haemorrhage.
• Recent myocardial infarction (heart attack).
• Abdominal aortic aneurysm.
• Cerebral malformation.
• Retinal detachment.
• Presence of a pacemaker (requires careful coordination with cardiology).

The pre-ECT assessment typically involves:

• A standard pre-anaesthesia consultation, including a detailed medical history.
• Blood tests and an Electrocardiogram (ECG) to assess cardiovascular health.
• A dental check-up to mitigate potential dental trauma during the procedure.
• Brain imaging (MRI or CT scan) or an Electroencephalogram (EEG) to assess brain structure and electrical activity.

Crucially, informed consent from the patient is mandatory before commencing ECT. This ensures the patient fully understands the procedure, its potential benefits, and its risks.

The ECT Session: What to Expect

ECT sessions are meticulously planned and performed in a hospital or clinic setting by a multidisciplinary team, including a psychiatrist, an anaesthetist, and nursing staff. Patients are typically asked to fast and withhold certain medications before the procedure.

Here's a step-by-step overview of a typical ECT session:

1. Preparation: Upon arrival, an intravenous (IV) line is inserted, and monitoring equipment is attached to track heart rate, blood pressure, and oxygen levels. An EEG monitors brain electrical activity.
2. Anaesthesia: The anaesthetist administers a short-acting general anaesthetic through the IV, causing the patient to fall asleep for approximately five to ten minutes.
3. Muscle Relaxation: A muscle relaxant (such as suxamethonium, a curare-like drug) is then given to prevent muscle contractions during the induced seizure, thereby reducing the risk of injuries like fractures or dental trauma.
4. Oxygen Administration: Oxygen is provided via a face mask to ensure adequate brain oxygenation throughout the procedure.
5. Electrical Stimulation: The psychiatrist places two metal discs (electrodes) on specific areas of the scalp, either bilaterally (on both sides of the head) or unilaterally (on one side, typically the non-dominant side to minimise cognitive side effects). A controlled, low-intensity electrical current (around 0.8 amps) is delivered for a very brief period, usually less than eight seconds.
6. Induced Seizure: This current stimulates the brain, inducing a controlled epileptic seizure that typically lasts between 20 and 90 seconds. The muscle relaxant ensures that the patient's body remains still, with only minimal twitching.
7. Recovery: Once the stimulation is complete and the patient begins to wake, they are transferred to a recovery room for observation, usually for about an hour, before returning to the psychiatric ward.

Number of Sessions and Maintenance Therapy

The total number of ECT sessions and their frequency are determined by the treating psychiatrist based on the individual's condition and response to treatment. Typically, sessions are administered two to three times per week during the acute phase of treatment.

For an effective course of ECT, patients usually require an average of 6 to 15 sessions to achieve remission, though this number can vary. In cases of resistant depression, 10 to 12 bilateral sessions may be needed, compared to 6 to 8 for less severe episodes.

It's crucial to understand that the physiological effects of ECT do not extend indefinitely beyond the sessions. Without ongoing treatment, almost all patients will relapse within six months of a successful ECT course. Therefore, before the acute course concludes, it is essential to implement a maintenance plan. This may involve continuing medication, engaging in psychotherapy, joining support groups, or undergoing maintenance ECT sessions (e.g., once a month) to prevent relapse and preserve the improvements gained.

Potential Side Effects of ECT

While modern ECT is remarkably safe, like any medical procedure, it carries potential side effects. These are generally transient and well-managed.

Common, Immediate Side Effects:

• Headache: Can occur due to anaesthesia, the treatment itself, or prolonged fasting.
• Muscle Stiffness/Aches: A common side effect of the muscle relaxants used during the procedure.
• Nausea: May be caused by the anaesthesia or fasting.
• Disorientation: Patients may feel confused or disoriented immediately after waking from anaesthesia and the ECT session. This usually subsides within a few hours, and it's advisable for patients to rest and have someone with them for the following 24 hours.
• Memory Loss: This is perhaps the most discussed side effect. Patients may experience problems with memory, including retrograde amnesia (difficulty recalling events from before the treatment) or anterograde amnesia (difficulty forming new memories). These episodes are usually temporary, lasting from a few weeks to several months. Modern ECT techniques and clearer guidelines have significantly reduced the risk and severity of memory impairment. Patients are generally advised to avoid making important decisions during their course of ECT.

Rare, More Severe Risks:

The mortality rate associated with ECT is extremely low, comparable to that of general anaesthesia for minor surgical procedures (approximately 1 in 10,000 patients treated or 2 in 100,000 sessions). Morbidity (complications) is also rare, estimated at 1 accident per 1,300 to 1,400 sessions. These can include:

• Laryngospasm (spasm of the vocal cords).
• Dental trauma (if muscle relaxation is insufficient).
• Joint dislocation or fracture (extremely rare with adequate muscle relaxants).
• Circulatory failure.
• Skin burns at the electrode application sites (very rare with proper technique).

The Enduring Value of ECT

Despite its historical baggage, ECT remains a critical and often underutilised therapeutic resource in modern psychiatry. Its ability to provide rapid and profound relief for individuals suffering from severe, treatment-resistant mental illnesses, particularly depression, is unparalleled by many other treatments. For patients who have endured years of ineffective medication regimens, ECT can literally 'bring them back to life', significantly improving their quality of life and functional capacity.

The ongoing research into its mechanisms of action continues to refine our understanding and improve its application, solidifying its place as a safe and effective option for those who need it most.

Frequently Asked Questions About ECT

Is ECT a painful procedure?

No, ECT is not painful. It is always performed under general anaesthesia, meaning you will be asleep and feel nothing during the procedure. Muscle relaxants are also administered to prevent any physical discomfort or injury from the induced seizure.

Is modern ECT the same as the 'shock therapy' depicted in old films?

Absolutely not. Modern ECT is a highly refined medical procedure that bears little resemblance to the crude, unanaesthetised 'electroshock therapy' of the past. Today's ECT is carefully controlled, administered with anaesthesia and muscle relaxants, and involves precise electrical currents to induce a therapeutic seizure, prioritising patient safety and comfort above all else.

How long do the beneficial effects of ECT last?

The immediate benefits of an ECT course can be profound, often leading to remission of severe symptoms. However, without follow-up care, the effects are generally not long-lasting. To prevent relapse, it is crucial to engage in maintenance therapy, which may include ongoing medication, psychotherapy, or periodic maintenance ECT sessions. This helps to sustain the improvements gained.

Can ECT cure mental illness?

ECT is a highly effective treatment for severe symptoms of certain mental illnesses, particularly depression, but it is not typically considered a 'cure'. Instead, it is a powerful intervention that can bring about remission and significantly improve symptoms when other treatments have failed. It is often part of a broader, ongoing treatment plan that may include medication and psychotherapy to maintain well-being.

Are there any long-term memory problems from ECT?

While temporary memory loss (both for recent events and sometimes events preceding treatment) is a known side effect, significant long-term or permanent memory impairment is rare with modern ECT techniques. Most memory issues resolve within weeks to months after treatment. Improved techniques, such as unilateral electrode placement, are designed to minimise cognitive side effects.

If you want to read more articles similar to Electroconvulsive Therapy: Your Guide to ECT, you can visit the Automotive category.